CNR1 and amyotrophic lateral sclerosis: The authors suggest that this may be indicative of a neuroprotective action compensating for initial losses in CB1R, though ultimately, expression of CB1R was reduced in end-stage ALS mouse models, suggesting continued declination in neuronal health (Zhao et al., 2008).